Higher cancer antigen 125 level is associated with the presence of permanent atrial fibrillation in systolic heart failure patients

Kaya H., Zorlu A., YÜCEL H., TATLISU M. A., KIVRAK T., COŞKUN A., ...Daha Fazla

ACTA CARDIOLOGICA, cilt.71, sa.1, ss.61-66, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 71 Sayı: 1
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1080/ac.71.1.3132099
  • Dergi Adı: ACTA CARDIOLOGICA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.61-66
  • Anahtar Kelimeler: Cancer antigen-125, CA-125, systolic heart failure, atrial fibrillation, C-REACTIVE PROTEIN, CARBOHYDRATE ANTIGEN-125, PROGNOSTIC-SIGNIFICANCE, OVARIAN-CANCER, CA-125 LEVELS, SERUM, INFLAMMATION, RECOMMENDATIONS, ELEVATION, BENIGN
  • Çanakkale Onsekiz Mart Üniversitesi Adresli: Hayır

Özet

Introduction Atrial fibrillation (AF) is a common arrhythmia in heart failure (HF). Recent studies have shown that serum cancer antigen-125 (CA-125) levels are elevated in HF, and high levels of CA-125 in HF patients with sinus rhythm have been shown to be associated with the development of new onset AF. However, the relation between CA-125 levels and the presence of AF in HF is unknown. In this study we investigated whether plasma CA-125 levels in patients with systolic HF could predict the presence of AF.